Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY: OGEN )

0.2872 +0.0022 (+0.77%)
Official Closing Price Updated: 4:10 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 271,740
Open 0.2900
Bid (Size) 0.2850 (10)
Ask (Size) 0.2888 (10)
Prev. Close 0.2850
Today's Range 0.2801 - 0.2941
52wk Range 0.2500 - 3.430
Shares Outstanding 12,212,680
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks — Oragenics Inc. Advances Concussion Treatment with Phase II Trial Preparation
Via Investor Brand Network
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Highlights Concussion Treatment Advances at Emergencies in Medicine Conference
Via Investor Brand Network

Performance

YTD
-20.20%
-20.20%
1 Month
-0.10%
-0.10%
3 Month
-19.28%
-19.28%
6 Month
-42.56%
-42.56%
1 Year
-79.92%
-79.92%

More News

Read More
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Appoints Chief Medical Officer to Medical Board of The Leigh Steinberg Foundation
Via Investor Brand Network
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Partners With BRAINBox Solutions to Advance Concussion Care
Via Investor Brand Network
Most active stocks in Wednesday's session
Via Chartmill
What's going on in today's session
Via Chartmill
The market is filled with gapping stocks in Wednesday's session.
Via Chartmill
US Stocks Mixed; Walt Disney Posts Upbeat Earnings
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Chief Medical Officer to Speak at Brain Health Summit During Super Bowl Week
Via Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Advances ONP-002 Development, Appoints Janet Huffman as Interim CEO
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Streamlines Capital Structure with Preferred Stock Conversion
Via Investor Brand Network
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Oragenics to Present at Centurion One Capital 2nd Annual Bahamas Summit
Via Investor Brand Network
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
BioMedNewsBreaks — Oragenics, Inc. (NYSE American: OGEN) Reports on Lead Candidate Drug Development, ‘Urgency’ to Advance First-in-Class Concussion Treatment
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Advances Concussion Treatment with Promising Study for Nasal Spray Drug ONP-002
Via Investor Brand Network
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate
Via Benzinga
Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Closes on $4.45M Public Offering
Via Investor Brand Network
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.